img

Global Etoricoxib Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Etoricoxib Market Insights, Forecast to 2034

Etoricoxib is a selective COX-2 inhibitor used to relieve dental pain after moderate surgery as a short-term treatment and inflammation and pain symptoms of various forms of arthritis.
The global Etoricoxib market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Etoricoxib is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Etoricoxib is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Etoricoxib is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key manufacturers of Etoricoxib include Morepen Laboratories, Merck & Co, Frosst Iberica SA, Metrochem API, Atom Pharma, Hema Pharmaceuticals, Beijing Tide Pharmaceutical, Qilu Pharmaceutical and Shanghai Shyndec Pharmaceutical, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes


This report presents an overview of global market for Etoricoxib, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Etoricoxib, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Etoricoxib, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Etoricoxib sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2024. Identification of the major stakeholders in the global Etoricoxib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2034. Evaluation and forecast the market size for Etoricoxib sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Morepen Laboratories, Merck & Co, Frosst Iberica SA, Metrochem API, Atom Pharma, Hema Pharmaceuticals, Beijing Tide Pharmaceutical, Qilu Pharmaceutical and Shanghai Shyndec Pharmaceutical, etc.



By Company


Morepen Laboratories
Merck & Co
Frosst Iberica SA
Metrochem API
Atom Pharma
Hema Pharmaceuticals
Beijing Tide Pharmaceutical
Qilu Pharmaceutical
Shanghai Shyndec Pharmaceutical
Easton Biopharmaceuticals
Segment by Type
30 mg
60 mg
90 mg
120 mg

Segment by Application


Hospital
Pharmacy
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Etoricoxib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of Etoricoxib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8China by type, by application sales and revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Etoricoxib sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Etoricoxib Product Introduction
1.2 Market by Type
1.2.1 Global Etoricoxib Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 30 mg
1.2.3 60 mg
1.2.4 90 mg
1.2.5 120 mg
1.3 Market by Application
1.3.1 Global Etoricoxib Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Etoricoxib Sales Estimates and Forecasts 2018-2034
2.2 Global Etoricoxib Revenue by Region
2.2.1 Global Etoricoxib Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global Etoricoxib Revenue by Region (2018-2024)
2.2.3 Global Etoricoxib Revenue by Region (2024-2034)
2.2.4 Global Etoricoxib Revenue Market Share by Region (2018-2034)
2.3 Global Etoricoxib Sales Estimates and Forecasts 2018-2034
2.4 Global Etoricoxib Sales by Region
2.4.1 Global Etoricoxib Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global Etoricoxib Sales by Region (2018-2024)
2.4.3 Global Etoricoxib Sales by Region (2024-2034)
2.4.4 Global Etoricoxib Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Etoricoxib Sales by Manufacturers
3.1.1 Global Etoricoxib Sales by Manufacturers (2018-2024)
3.1.2 Global Etoricoxib Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Etoricoxib in 2022
3.2 Global Etoricoxib Revenue by Manufacturers
3.2.1 Global Etoricoxib Revenue by Manufacturers (2018-2024)
3.2.2 Global Etoricoxib Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Etoricoxib Revenue in 2022
3.3 Global Key Players of Etoricoxib, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Etoricoxib Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Etoricoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Etoricoxib, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Etoricoxib, Product Offered and Application
3.8 Global Key Manufacturers of Etoricoxib, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Etoricoxib Sales by Type
4.1.1 Global Etoricoxib Historical Sales by Type (2018-2024)
4.1.2 Global Etoricoxib Forecasted Sales by Type (2024-2034)
4.1.3 Global Etoricoxib Sales Market Share by Type (2018-2034)
4.2 Global Etoricoxib Revenue by Type
4.2.1 Global Etoricoxib Historical Revenue by Type (2018-2024)
4.2.2 Global Etoricoxib Forecasted Revenue by Type (2024-2034)
4.2.3 Global Etoricoxib Revenue Market Share by Type (2018-2034)
4.3 Global Etoricoxib Price by Type
4.3.1 Global Etoricoxib Price by Type (2018-2024)
4.3.2 Global Etoricoxib Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Etoricoxib Sales by Application
5.1.1 Global Etoricoxib Historical Sales by Application (2018-2024)
5.1.2 Global Etoricoxib Forecasted Sales by Application (2024-2034)
5.1.3 Global Etoricoxib Sales Market Share by Application (2018-2034)
5.2 Global Etoricoxib Revenue by Application
5.2.1 Global Etoricoxib Historical Revenue by Application (2018-2024)
5.2.2 Global Etoricoxib Forecasted Revenue by Application (2024-2034)
5.2.3 Global Etoricoxib Revenue Market Share by Application (2018-2034)
5.3 Global Etoricoxib Price by Application
5.3.1 Global Etoricoxib Price by Application (2018-2024)
5.3.2 Global Etoricoxib Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Etoricoxib Market Size by Type
6.1.1 US & Canada Etoricoxib Sales by Type (2018-2034)
6.1.2 US & Canada Etoricoxib Revenue by Type (2018-2034)
6.2 US & Canada Etoricoxib Market Size by Application
6.2.1 US & Canada Etoricoxib Sales by Application (2018-2034)
6.2.2 US & Canada Etoricoxib Revenue by Application (2018-2034)
6.3 US & Canada Etoricoxib Market Size by Country
6.3.1 US & Canada Etoricoxib Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada Etoricoxib Sales by Country (2018-2034)
6.3.3 US & Canada Etoricoxib Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Etoricoxib Market Size by Type
7.1.1 Europe Etoricoxib Sales by Type (2018-2034)
7.1.2 Europe Etoricoxib Revenue by Type (2018-2034)
7.2 Europe Etoricoxib Market Size by Application
7.2.1 Europe Etoricoxib Sales by Application (2018-2034)
7.2.2 Europe Etoricoxib Revenue by Application (2018-2034)
7.3 Europe Etoricoxib Market Size by Country
7.3.1 Europe Etoricoxib Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe Etoricoxib Sales by Country (2018-2034)
7.3.3 Europe Etoricoxib Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Etoricoxib Market Size
8.1.1 China Etoricoxib Sales (2018-2034)
8.1.2 China Etoricoxib Revenue (2018-2034)
8.2 China Etoricoxib Market Size by Application
8.2.1 China Etoricoxib Sales by Application (2018-2034)
8.2.2 China Etoricoxib Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Etoricoxib Market Size by Type
9.1.1 Asia Etoricoxib Sales by Type (2018-2034)
9.1.2 Asia Etoricoxib Revenue by Type (2018-2034)
9.2 Asia Etoricoxib Market Size by Application
9.2.1 Asia Etoricoxib Sales by Application (2018-2034)
9.2.2 Asia Etoricoxib Revenue by Application (2018-2034)
9.3 Asia Etoricoxib Sales by Region
9.3.1 Asia Etoricoxib Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia Etoricoxib Revenue by Region (2018-2034)
9.3.3 Asia Etoricoxib Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Etoricoxib Market Size by Type
10.1.1 Middle East, Africa and Latin America Etoricoxib Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Etoricoxib Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Etoricoxib Market Size by Application
10.2.1 Middle East, Africa and Latin America Etoricoxib Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Etoricoxib Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Etoricoxib Sales by Country
10.3.1 Middle East, Africa and Latin America Etoricoxib Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Etoricoxib Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Etoricoxib Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Morepen Laboratories
11.1.1 Morepen Laboratories Company Information
11.1.2 Morepen Laboratories Overview
11.1.3 Morepen Laboratories Etoricoxib Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Morepen Laboratories Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Morepen Laboratories Recent Developments
11.2 Merck & Co
11.2.1 Merck & Co Company Information
11.2.2 Merck & Co Overview
11.2.3 Merck & Co Etoricoxib Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Merck & Co Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck & Co Recent Developments
11.3 Frosst Iberica SA
11.3.1 Frosst Iberica SA Company Information
11.3.2 Frosst Iberica SA Overview
11.3.3 Frosst Iberica SA Etoricoxib Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Frosst Iberica SA Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Frosst Iberica SA Recent Developments
11.4 Metrochem API
11.4.1 Metrochem API Company Information
11.4.2 Metrochem API Overview
11.4.3 Metrochem API Etoricoxib Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Metrochem API Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Metrochem API Recent Developments
11.5 Atom Pharma
11.5.1 Atom Pharma Company Information
11.5.2 Atom Pharma Overview
11.5.3 Atom Pharma Etoricoxib Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Atom Pharma Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Atom Pharma Recent Developments
11.6 Hema Pharmaceuticals
11.6.1 Hema Pharmaceuticals Company Information
11.6.2 Hema Pharmaceuticals Overview
11.6.3 Hema Pharmaceuticals Etoricoxib Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Hema Pharmaceuticals Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hema Pharmaceuticals Recent Developments
11.7 Beijing Tide Pharmaceutical
11.7.1 Beijing Tide Pharmaceutical Company Information
11.7.2 Beijing Tide Pharmaceutical Overview
11.7.3 Beijing Tide Pharmaceutical Etoricoxib Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Beijing Tide Pharmaceutical Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Beijing Tide Pharmaceutical Recent Developments
11.8 Qilu Pharmaceutical
11.8.1 Qilu Pharmaceutical Company Information
11.8.2 Qilu Pharmaceutical Overview
11.8.3 Qilu Pharmaceutical Etoricoxib Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Qilu Pharmaceutical Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Qilu Pharmaceutical Recent Developments
11.9 Shanghai Shyndec Pharmaceutical
11.9.1 Shanghai Shyndec Pharmaceutical Company Information
11.9.2 Shanghai Shyndec Pharmaceutical Overview
11.9.3 Shanghai Shyndec Pharmaceutical Etoricoxib Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Shanghai Shyndec Pharmaceutical Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Shanghai Shyndec Pharmaceutical Recent Developments
11.10 Easton Biopharmaceuticals
11.10.1 Easton Biopharmaceuticals Company Information
11.10.2 Easton Biopharmaceuticals Overview
11.10.3 Easton Biopharmaceuticals Etoricoxib Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Easton Biopharmaceuticals Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Easton Biopharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Etoricoxib Industry Chain Analysis
12.2 Etoricoxib Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Etoricoxib Production Mode & Process
12.4 Etoricoxib Sales and Marketing
12.4.1 Etoricoxib Sales Channels
12.4.2 Etoricoxib Distributors
12.5 Etoricoxib Customers
13 Market Dynamics
13.1 Etoricoxib Industry Trends
13.2 Etoricoxib Market Drivers
13.3 Etoricoxib Market Challenges
13.4 Etoricoxib Market Restraints
14 Key Findings in The Global Etoricoxib Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Etoricoxib Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of 30 mg
Table 3. Major Manufacturers of 60 mg
Table 4. Major Manufacturers of 90 mg
Table 5. Major Manufacturers of 120 mg
Table 6. Global Etoricoxib Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Etoricoxib Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Etoricoxib Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Etoricoxib Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Etoricoxib Revenue Market Share by Region (2018-2024)
Table 11. Global Etoricoxib Revenue Market Share by Region (2024-2034)
Table 12. Global Etoricoxib Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 13. Global Etoricoxib Sales by Region (2018-2024) & (K Units)
Table 14. Global Etoricoxib Sales by Region (2024-2034) & (K Units)
Table 15. Global Etoricoxib Sales Market Share by Region (2018-2024)
Table 16. Global Etoricoxib Sales Market Share by Region (2024-2034)
Table 17. Global Etoricoxib Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Etoricoxib Sales Share by Manufacturers (2018-2024)
Table 19. Global Etoricoxib Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Etoricoxib Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Etoricoxib, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Etoricoxib Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Etoricoxib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Etoricoxib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Etoricoxib as of 2022)
Table 25. Global Key Manufacturers of Etoricoxib, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Etoricoxib, Product Offered and Application
Table 27. Global Key Manufacturers of Etoricoxib, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Etoricoxib Sales by Type (2018-2024) & (K Units)
Table 30. Global Etoricoxib Sales by Type (2024-2034) & (K Units)
Table 31. Global Etoricoxib Sales Share by Type (2018-2024)
Table 32. Global Etoricoxib Sales Share by Type (2024-2034)
Table 33. Global Etoricoxib Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Etoricoxib Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Etoricoxib Revenue Share by Type (2018-2024)
Table 36. Global Etoricoxib Revenue Share by Type (2024-2034)
Table 37. Etoricoxib Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Etoricoxib Price Forecast by Type (2024-2034) & (US$/Unit)
Table 39. Global Etoricoxib Sales by Application (2018-2024) & (K Units)
Table 40. Global Etoricoxib Sales by Application (2024-2034) & (K Units)
Table 41. Global Etoricoxib Sales Share by Application (2018-2024)
Table 42. Global Etoricoxib Sales Share by Application (2024-2034)
Table 43. Global Etoricoxib Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Etoricoxib Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Etoricoxib Revenue Share by Application (2018-2024)
Table 46. Global Etoricoxib Revenue Share by Application (2024-2034)
Table 47. Etoricoxib Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Etoricoxib Price Forecast by Application (2024-2034) & (US$/Unit)
Table 49. US & Canada Etoricoxib Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Etoricoxib Sales by Type (2024-2034) & (K Units)
Table 51. US & Canada Etoricoxib Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Etoricoxib Revenue by Type (2024-2034) & (US$ Million)
Table 53. US & Canada Etoricoxib Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Etoricoxib Sales by Application (2024-2034) & (K Units)
Table 55. US & Canada Etoricoxib Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Etoricoxib Revenue by Application (2024-2034) & (US$ Million)
Table 57. US & Canada Etoricoxib Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. US & Canada Etoricoxib Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Etoricoxib Revenue by Country (2024-2034) & (US$ Million)
Table 60. US & Canada Etoricoxib Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Etoricoxib Sales by Country (2024-2034) & (K Units)
Table 62. Europe Etoricoxib Sales by Type (2018-2024) & (K Units)
Table 63. Europe Etoricoxib Sales by Type (2024-2034) & (K Units)
Table 64. Europe Etoricoxib Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Etoricoxib Revenue by Type (2024-2034) & (US$ Million)
Table 66. Europe Etoricoxib Sales by Application (2018-2024) & (K Units)
Table 67. Europe Etoricoxib Sales by Application (2024-2034) & (K Units)
Table 68. Europe Etoricoxib Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Etoricoxib Revenue by Application (2024-2034) & (US$ Million)
Table 70. Europe Etoricoxib Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 71. Europe Etoricoxib Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Etoricoxib Revenue by Country (2024-2034) & (US$ Million)
Table 73. Europe Etoricoxib Sales by Country (2018-2024) & (K Units)
Table 74. Europe Etoricoxib Sales by Country (2024-2034) & (K Units)
Table 75. China Etoricoxib Sales by Type (2018-2024) & (K Units)
Table 76. China Etoricoxib Sales by Type (2024-2034) & (K Units)
Table 77. China Etoricoxib Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Etoricoxib Revenue by Type (2024-2034) & (US$ Million)
Table 79. China Etoricoxib Sales by Application (2018-2024) & (K Units)
Table 80. China Etoricoxib Sales by Application (2024-2034) & (K Units)
Table 81. China Etoricoxib Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Etoricoxib Revenue by Application (2024-2034) & (US$ Million)
Table 83. Asia Etoricoxib Sales by Type (2018-2024) & (K Units)
Table 84. Asia Etoricoxib Sales by Type (2024-2034) & (K Units)
Table 85. Asia Etoricoxib Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Etoricoxib Revenue by Type (2024-2034) & (US$ Million)
Table 87. Asia Etoricoxib Sales by Application (2018-2024) & (K Units)
Table 88. Asia Etoricoxib Sales by Application (2024-2034) & (K Units)
Table 89. Asia Etoricoxib Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Etoricoxib Revenue by Application (2024-2034) & (US$ Million)
Table 91. Asia Etoricoxib Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 92. Asia Etoricoxib Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Etoricoxib Revenue by Region (2024-2034) & (US$ Million)
Table 94. Asia Etoricoxib Sales by Region (2018-2024) & (K Units)
Table 95. Asia Etoricoxib Sales by Region (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America Etoricoxib Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Etoricoxib Sales by Type (2024-2034) & (K Units)
Table 98. Middle East, Africa and Latin America Etoricoxib Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Etoricoxib Revenue by Type (2024-2034) & (US$ Million)
Table 100. Middle East, Africa and Latin America Etoricoxib Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Etoricoxib Sales by Application (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Etoricoxib Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Etoricoxib Revenue by Application (2024-2034) & (US$ Million)
Table 104. Middle East, Africa and Latin America Etoricoxib Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 105. Middle East, Africa and Latin America Etoricoxib Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Etoricoxib Revenue by Country (2024-2034) & (US$ Million)
Table 107. Middle East, Africa and Latin America Etoricoxib Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Etoricoxib Sales by Country (2024-2034) & (K Units)
Table 109. Morepen Laboratories Company Information
Table 110. Morepen Laboratories Description and Major Businesses
Table 111. Morepen Laboratories Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Morepen Laboratories Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Morepen Laboratories Recent Developments
Table 114. Merck & Co Company Information
Table 115. Merck & Co Description and Major Businesses
Table 116. Merck & Co Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Merck & Co Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Merck & Co Recent Developments
Table 119. Frosst Iberica SA Company Information
Table 120. Frosst Iberica SA Description and Major Businesses
Table 121. Frosst Iberica SA Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Frosst Iberica SA Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Frosst Iberica SA Recent Developments
Table 124. Metrochem API Company Information
Table 125. Metrochem API Description and Major Businesses
Table 126. Metrochem API Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Metrochem API Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Metrochem API Recent Developments
Table 129. Atom Pharma Company Information
Table 130. Atom Pharma Description and Major Businesses
Table 131. Atom Pharma Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Atom Pharma Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Atom Pharma Recent Developments
Table 134. Hema Pharmaceuticals Company Information
Table 135. Hema Pharmaceuticals Description and Major Businesses
Table 136. Hema Pharmaceuticals Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Hema Pharmaceuticals Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Hema Pharmaceuticals Recent Developments
Table 139. Beijing Tide Pharmaceutical Company Information
Table 140. Beijing Tide Pharmaceutical Description and Major Businesses
Table 141. Beijing Tide Pharmaceutical Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Beijing Tide Pharmaceutical Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Beijing Tide Pharmaceutical Recent Developments
Table 144. Qilu Pharmaceutical Company Information
Table 145. Qilu Pharmaceutical Description and Major Businesses
Table 146. Qilu Pharmaceutical Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Qilu Pharmaceutical Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Qilu Pharmaceutical Recent Developments
Table 149. Shanghai Shyndec Pharmaceutical Company Information
Table 150. Shanghai Shyndec Pharmaceutical Description and Major Businesses
Table 151. Shanghai Shyndec Pharmaceutical Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Shanghai Shyndec Pharmaceutical Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Shanghai Shyndec Pharmaceutical Recent Developments
Table 154. Easton Biopharmaceuticals Company Information
Table 155. Easton Biopharmaceuticals Description and Major Businesses
Table 156. Easton Biopharmaceuticals Etoricoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Easton Biopharmaceuticals Etoricoxib Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Easton Biopharmaceuticals Recent Developments
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Etoricoxib Distributors List
Table 162. Etoricoxib Customers List
Table 163. Etoricoxib Market Trends
Table 164. Etoricoxib Market Drivers
Table 165. Etoricoxib Market Challenges
Table 166. Etoricoxib Market Restraints
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Etoricoxib Product Picture
Figure 2. Global Etoricoxib Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Etoricoxib Market Share by Type in 2022 & 2034
Figure 4. 30 mg Product Picture
Figure 5. 60 mg Product Picture
Figure 6. 90 mg Product Picture
Figure 7. 120 mg Product Picture
Figure 8. Global Etoricoxib Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Etoricoxib Market Share by Application in 2022 & 2034
Figure 10. Hospital
Figure 11. Pharmacy
Figure 12. Others
Figure 13. Etoricoxib Report Years Considered
Figure 14. Global Etoricoxib Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Etoricoxib Revenue 2018-2034 (US$ Million)
Figure 16. Global Etoricoxib Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 17. Global Etoricoxib Revenue Market Share by Region (2018-2034)
Figure 18. Global Etoricoxib Sales 2018-2034 ((K Units)
Figure 19. Global Etoricoxib Sales Market Share by Region (2018-2034)
Figure 20. US & Canada Etoricoxib Sales YoY (2018-2034) & (K Units)
Figure 21. US & Canada Etoricoxib Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Etoricoxib Sales YoY (2018-2034) & (K Units)
Figure 23. Europe Etoricoxib Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Etoricoxib Sales YoY (2018-2034) & (K Units)
Figure 25. China Etoricoxib Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Asia (excluding China) Etoricoxib Sales YoY (2018-2034) & (K Units)
Figure 27. Asia (excluding China) Etoricoxib Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Etoricoxib Sales YoY (2018-2034) & (K Units)
Figure 29. Middle East, Africa and Latin America Etoricoxib Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Etoricoxib Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Etoricoxib in the World: Market Share by Etoricoxib Revenue in 2022
Figure 32. Global Etoricoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Etoricoxib Sales Market Share by Type (2018-2034)
Figure 34. Global Etoricoxib Revenue Market Share by Type (2018-2034)
Figure 35. Global Etoricoxib Sales Market Share by Application (2018-2034)
Figure 36. Global Etoricoxib Revenue Market Share by Application (2018-2034)
Figure 37. US & Canada Etoricoxib Sales Market Share by Type (2018-2034)
Figure 38. US & Canada Etoricoxib Revenue Market Share by Type (2018-2034)
Figure 39. US & Canada Etoricoxib Sales Market Share by Application (2018-2034)
Figure 40. US & Canada Etoricoxib Revenue Market Share by Application (2018-2034)
Figure 41. US & Canada Etoricoxib Revenue Share by Country (2018-2034)
Figure 42. US & Canada Etoricoxib Sales Share by Country (2018-2034)
Figure 43. U.S. Etoricoxib Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Etoricoxib Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Etoricoxib Sales Market Share by Type (2018-2034)
Figure 46. Europe Etoricoxib Revenue Market Share by Type (2018-2034)
Figure 47. Europe Etoricoxib Sales Market Share by Application (2018-2034)
Figure 48. Europe Etoricoxib Revenue Market Share by Application (2018-2034)
Figure 49. Europe Etoricoxib Revenue Share by Country (2018-2034)
Figure 50. Europe Etoricoxib Sales Share by Country (2018-2034)
Figure 51. Germany Etoricoxib Revenue (2018-2034) & (US$ Million)
Figure 52. France Etoricoxib Revenue (2018-2034) & (US$ Million)
Figure 53. U.K. Etoricoxib Revenue (2018-2034) & (US$ Million)
Figure 54. Italy Etoricoxib Revenue (2018-2034) & (US$ Million)
Figure 55. Russia Etoricoxib Revenue (2018-2034) & (US$ Million)
Figure 56. China Etoricoxib Sales Market Share by Type (2018-2034)
Figure 57. China Etoricoxib Revenue Market Share by Type (2018-2034)
Figure 58. China Etoricoxib Sales Market Share by Application (2018-2034)
Figure 59. China Etoricoxib Revenue Market Share by Application (2018-2034)
Figure 60. Asia Etoricoxib Sales Market Share by Type (2018-2034)
Figure 61. Asia Etoricoxib Revenue Market Share by Type (2018-2034)
Figure 62. Asia Etoricoxib Sales Market Share by Application (2018-2034)
Figure 63. Asia Etoricoxib Revenue Market Share by Application (2018-2034)
Figure 64. Asia Etoricoxib Revenue Share by Region (2018-2034)
Figure 65. Asia Etoricoxib Sales Share by Region (2018-2034)
Figure 66. Japan Etoricoxib Revenue (2018-2034) & (US$ Million)
Figure 67. South Korea Etoricoxib Revenue (2018-2034) & (US$ Million)
Figure 68. China Taiwan Etoricoxib Revenue (2018-2034) & (US$ Million)
Figure 69. Southeast Asia Etoricoxib Revenue (2018-2034) & (US$ Million)
Figure 70. India Etoricoxib Revenue (2018-2034) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Etoricoxib Sales Market Share by Type (2018-2034)
Figure 72. Middle East, Africa and Latin America Etoricoxib Revenue Market Share by Type (2018-2034)
Figure 73. Middle East, Africa and Latin America Etoricoxib Sales Market Share by Application (2018-2034)
Figure 74. Middle East, Africa and Latin America Etoricoxib Revenue Market Share by Application (2018-2034)
Figure 75. Middle East, Africa and Latin America Etoricoxib Revenue Share by Country (2018-2034)
Figure 76. Middle East, Africa and Latin America Etoricoxib Sales Share by Country (2018-2034)
Figure 77. Brazil Etoricoxib Revenue (2018-2034) & (US$ Million)
Figure 78. Mexico Etoricoxib Revenue (2018-2034) & (US$ Million)
Figure 79. Turkey Etoricoxib Revenue (2018-2034) & (US$ Million)
Figure 80. Israel Etoricoxib Revenue (2018-2034) & (US$ Million)
Figure 81. GCC Countries Etoricoxib Revenue (2018-2034) & (US$ Million)
Figure 82. Etoricoxib Value Chain
Figure 83. Etoricoxib Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed